Lauren Renee Lilley Lohmer

Lauren Renee Lilley Lohmer currently serves as the Director of Quantitative Clinical Pharmacology at Indivior, beginning in March 2024. Prior to this role, Lauren held the position of Director of Clinical Pharmacology and Pharmacometrics at Taiho Oncology, Inc. from November 2022 to March 2024. Lauren's extensive experience in clinical pharmacology spans several leadership roles at Nuventra Pharma Sciences, where contributions to over 18 regulatory approvals were made, and at Duke University, where a PhD in Cell/Cellular and Molecular Biology was obtained. Throughout the career, Lauren has demonstrated expertise in pharmacokinetic analysis, pharmacometric modeling, project management, and scientific writing, supported by a foundational education in biological sciences from the University of Notre Dame.